Skip to main content
. 2015 Jul 1;35(7):499–512. doi: 10.1089/jir.2015.0015

Table 1.

Serum IL-35 as a Diagnostic Biomarker for Cancer and Autoimmune Diseases

Disease/model IL-35 expression References
Elevated circulating IL-35 levels in human cancer
 Colorectal cancer Serum IL-35 levels are positively correlated with Treg numbers in the peripheral blood of colorectal cancer patients and reduction in serum IL-35 following tumor resection Zeng and others (2013)
 Pancreatic ductal adenocarcinoma Increased plasma IL-35 levels associated with lymph node metastasis and late-stage tumor Jin and others (2014)
 Acute myeloid leukemia Increased plasma IL-35 concentration has also been correlative in newly diagnosed acute myeloid leukemia patients, one of the most common hematological malignancy in adults Wu and others (2012)
Reduced circulating IL-35 levels in human autoimmune diseases
 Multiple sclerosis (MS) Serum IL-35 levels were lower in MS patients and treatment with interferon β, methylprednisolone, or combination of both offered beneficial effects through the upregulation of IL-35 production Jafarzadeh and others (2015)
 Asthma and chronic obstructive pulmonary disease (COPD) Expression of IL-35 mRNA and protein were both downregulated in asthmatic children, and serum IL-35 level was inversely related to serum IL-4 and positively correlated with serum IFN-γ levels Chen and others (2014) and Ma and others (2014)
 Allergic rhinitis Serum IL-35 and Ebi3 expression was also significantly reduced in allergic rhinitis patients relative to normal controls Wan and others (2014)
 Ulcerative colitis (UC) and Crohn's disease (CD) Serum IL-35 levels were also significantly reduced in ulcerative colitis (UC) and Crohn's disease (CD) patients suggestive of insufficient anti-inflammatory activity in vivo. Li and others (2014)
 Immune thrombocytopenia (ITC) Reduced plasma IL-35 levels in active ITC patients than those in remission Yang and others (2014)
 Fetomaternal tolerance, recurrent pregnancy loss (RPL), and preeclampsia (PE) Decreased plasma IL-35 levels were noted in females with RPL and PE Ozkan and others (2014, 2015)
 Atherosclerosis and coronary artery diseases (CAD) Plasma IL-35 levels were significantly decreased in patients with stable and unstable angina pectoris (SAP and UAP) and acute myocardial infarction (AMI) Lin and others (2012)